Hjem › Blærekreft › Pennsylvania
Kliniske studier for Blærekreft i Pennsylvania
27 studier for Blærekreft søker deltakere på steder i Pennsylvania.
Byer i Pennsylvania
Offisiell studietekst (engelsk)
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Geisinger Medical Center, Danville
- Geisinger Cancer Center Dickson City, Dickson City
- Geisinger Medical Oncology-Lewisburg, Lewisburg
- og 3 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07000084Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Geisinger Medical Center, Danville
- og 7 flere
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Christiana Care Health System-Concord Health Center, Chadds Ford
- Geisinger Medical Center, Danville
- Geisinger Cancer Center Dickson City, Dickson City
- og 17 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06770582A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- MidLantic Urology ( Site 0102), Bala-Cynwyd
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06833073Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07061964Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Pocono Medical Center, East Stroudsburg
- og 8 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT03866382A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07277413DESTINY-PANTUMOUR04
- Research Site, Philadelphia
RekruttererObservasjonsstudie
Alder 18 til 130 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07124000A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Lancaster General Hospital - Ann B Barshinger Cancer Institute, Lancaster
- AHN Allegheny General Hospital, Pittsburgh
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07218380Prehabilitation in High-risk Oncologic Surgery
- Fox Chase Cancer Center - Philadelphia, Philadelphia
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07638410A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07217171ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of Pennsylvania, Philadelphia
- WellSpan Medical Oncology & Hematology at York Cancer Center, York
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT05059444Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Midlantic Urology (Solaris), Bala-Cynwyd
- Penn State University Milton S. Hershey Medical Center, Hershey
- Keystone Urology Specialists, Lancaster
- og 1 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06567743Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- University of Pittsburgh Medical Center, Pittsburgh
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05951179FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Penn Medicine Lancaster General Hospital - Ann B. Barshinger Cancer Institute, Lancaster
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University, Philadelphia
- og 2 flere
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT05614739Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- Christiana Care Health System-Concord Health Center, Chadds Ford
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT07097142LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 7. aug. 2026 · NCT04752722A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Thomas Jefferson University, Philadelphia
RekruttererFase 2
Alder 8 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT05503797Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
- Penn State Medical Center, Urology Research, Hershey
Rekrutterer
Alder 18 til 88 · Alle kjønn · Oppdatert 2. jul. 2026 · NCT06394869Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer
- University of Pennsylvania, Philadelphia
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 14. mai 2026 · NCT06586255Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
- Abramson Cancer Center, Philadelphia
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 13. mai 2026 · NCT07048496The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Allegheny Health Network, Pittsburgh
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 5. mar. 2026 · NCT04075305Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- University of Pennsylvania, Philadelphia
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 18. feb. 2026 · NCT07030257Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Einstein Philadelphia Hospital, Philadelphia
Rekrutterer
Alder 18 til 85 · Alle kjønn · Oppdatert 17. feb. 2026 · NCT07234968A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 13. feb. 2026 · NCT06778863Virtual Histology of the Bladder Wall for Bladder Cancer Staging
- UPMC Hillman Cancer Center - Dept of Urology, Pittsburgh
RekruttererTidlig fase 1
Alder 18 til 90 · Alle kjønn · Oppdatert 17. des. 2025 · NCT04369560SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Philadelphia
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.